“…The study did not account for confounding variables that can influence the prognosis, such as comorbidities like hypertension, diabetes mellitus, and obesity. 2 Patients’ concurrent medications and socioeconomic status remain unevaluated. Moreover, only the Chinese population was studied which can limit its application.…”